Update: 20.08.2024
Last week: 32 week 2024 (05.08.2024 - 11.08.2024)
Last full month: July 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 860 | 7.9% | 14.1% | 1.1 | 15 022 475 | 12.0% | 10.2% | 1.1 | -0.5% |
| MoM | 33 561 | 12.5% | 13.2% | 1.4 | 64 687 077 | 4.5% | 9.7% | 0.5 | 0.2% |
| YTD | 232 226 | 20.0% | 11.5% | 2.7 | 498 398 216 | 39.3% | 9.4% | 2 | -8.1% |
| MAT | 379 496 | 24.4% | 10.7% | 2 | 797 493 677 | 42.5% | 8.9% | 1.6 | 0.5% |
| BRAINMAX | |||||||||
| WoW | 1 410 | 40.9% | 100.0% | 0 | 5 650 664 | 51.3% | 100.0% | 0 | 40.9% |
| MoM | 5 212 | 11.0% | 100.0% | 0 | 19 612 893 | 12.5% | 100.0% | 0 | 11.2% |
| YTD | 34 088 | 40.5% | 100.0% | 0 | 125 187 195 | 52.8% | 100.0% | 0 | 40.5% |
| MAT | 56 481 | 64.8% | 100.0% | 0 | 204 248 228 | 79.1% | 100.0% | 0 | 64.8% |
| GOLDLINE PLUS | |||||||||
| WoW | 14 385 | -0.1% | 45.3% | -1.2 | 44 213 790 | -1.0% | 37.0% | -1.6 | 2.6% |
| MoM | 68 010 | -10.6% | 46.4% | 0.7 | 212 403 736 | -10.0% | 38.3% | 0.8 | -12.0% |
| YTD | 539 506 | -4.7% | 44.9% | 0.8 | 1 699 388 593 | -1.5% | 36.7% | -2.7 | -6.4% |
| MAT | 842 391 | 2.4% | 45.5% | 1 | 2 666 530 203 | 8.5% | 37.9% | -1.6 | 0.2% |
| MIGRENIUM | |||||||||
| WoW | 12 411 | 21.3% | 0.6% | 0.1 | 4 123 609 | 18.4% | 0.8% | 0.1 | -0.7% |
| MoM | 45 770 | -3.4% | 0.5% | -0.1 | 15 433 925 | -1.3% | 0.6% | -0.1 | 11.3% |
| YTD | 375 606 | -7.1% | 0.5% | -0.1 | 116 272 718 | 58.4% | 0.7% | 0.2 | 8.8% |
| MAT | 612 976 | -6.3% | 0.5% | -0.1 | 165 512 158 | 39.2% | 0.6% | 0.1 | 12.3% |
| MODELAX-N | |||||||||
| WoW | 24 541 | 17.7% | 20.6% | 3 | 11 470 150 | 16.2% | 13.7% | 2 | 0.7% |
| MoM | 102 999 | -20.7% | 19.3% | -6.2 | 48 116 412 | -16.9% | 13.0% | -4 | 4.9% |
| YTD | 935 082 | 33.8% | 22.9% | 4.1 | 402 585 937 | 82.9% | 14.7% | 4.3 | 9.5% |
| MAT | 1 403 949 | 55.1% | 21.2% | 5.4 | 565 246 900 | 95.0% | 13.1% | 4.1 | 15.8% |
| REDUXIN | |||||||||
| WoW | 10 427 | 4.7% | 32.8% | 0.7 | 52 733 780 | 5.0% | 44.2% | 0.8 | 2.6% |
| MoM | 48 170 | -9.4% | 32.8% | 1 | 247 736 086 | -11.8% | 44.6% | 0.1 | -12.0% |
| YTD | 395 099 | -8.7% | 32.9% | -0.8 | 2 114 930 833 | 13.9% | 45.7% | 3.2 | -6.4% |
| MAT | 600 166 | -4.7% | 32.4% | -1.7 | 3 130 932 411 | 17.8% | 44.5% | 1.8 | 0.2% |
| REDUXIN FORTE | |||||||||
| WoW | 3 312 | 13.3% | 10.4% | 1 | 14 224 440 | 14.0% | 11.9% | 1.1 | 2.6% |
| MoM | 13 691 | -8.3% | 9.3% | 0.4 | 57 980 483 | -10.1% | 10.4% | 0.2 | -12.0% |
| YTD | 106 145 | 0.1% | 8.8% | 0.6 | 459 895 908 | 13.8% | 9.9% | 0.7 | -6.4% |
| MAT | 166 127 | 10.8% | 9.0% | 0.9 | 709 416 583 | 23.6% | 10.1% | 0.9 | 0.2% |
| SALVISAR | |||||||||
| WoW | 8 285 | 6.9% | 1.2% | 0.1 | 3 574 930 | 3.1% | 1.1% | 0 | 0.1% |
| MoM | 34 936 | -11.1% | 1.1% | -0.2 | 15 667 203 | -7.6% | 1.1% | -0.1 | 2.1% |
| YTD | 319 220 | 1.6% | 1.4% | 0 | 130 006 571 | 27.1% | 1.2% | 0.1 | -1.5% |
| MAT | 503 286 | -11.8% | 1.3% | -0.2 | 191 430 973 | -0.1% | 1.1% | -0.2 | 3.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 232 226 | 20.0% | 11.5% | 2.7 | 498 398 216 | 39.3% | 9.4% | 2 | -8.1% |
| BRAINMAX | 34 088 | 40.5% | 100.0% | 0 | 125 187 195 | 52.8% | 100.0% | 0 | 40.5% |
| GOLDLINE PLUS | 539 506 | -4.7% | 44.9% | 0.8 | 1 699 388 593 | -1.5% | 36.7% | -2.7 | -6.4% |
| MIGRENIUM | 375 606 | -7.1% | 0.5% | -0.1 | 116 272 718 | 58.4% | 0.7% | 0.2 | 8.8% |
| MODELAX-N | 935 082 | 33.8% | 22.9% | 4.1 | 402 585 937 | 82.9% | 14.7% | 4.3 | 9.5% |
| REDUXIN CAPS | 395 099 | -8.7% | 32.9% | -0.8 | 2 114 930 833 | 13.9% | 45.7% | 3.2 | -6.4% |
| REDUXIN FORTE | 106 145 | 0.1% | 8.8% | 0.6 | 459 895 908 | 13.8% | 9.9% | 0.7 | -6.4% |
| SALVISAR | 319 220 | 1.6% | 1.4% | 0 | 130 006 571 | 27.1% | 1.2% | 0.1 | -1.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 379 496 | 24.4% | 10.7% | 2 | 797 493 677 | 42.5% | 8.9% | 1.6 | 0.5% |
| BRAINMAX | 56 481 | 64.8% | 100.0% | 0 | 204 248 228 | 79.1% | 100.0% | 0 | 64.8% |
| GOLDLINE PLUS | 842 391 | 2.4% | 45.5% | 1 | 2 666 530 203 | 8.5% | 37.9% | -1.6 | 0.2% |
| MIGRENIUM | 612 976 | -6.3% | 0.5% | -0.1 | 165 512 158 | 39.2% | 0.6% | 0.1 | 12.3% |
| MODELAX-N | 1 403 949 | 55.1% | 21.2% | 5.4 | 565 246 900 | 95.0% | 13.1% | 4.1 | 15.8% |
| REDUXIN CAPS | 600 166 | -4.7% | 32.4% | -1.7 | 3 130 932 411 | 17.8% | 44.5% | 1.8 | 0.2% |
| REDUXIN FORTE | 166 127 | 10.8% | 9.0% | 0.9 | 709 416 583 | 23.6% | 10.1% | 0.9 | 0.2% |
| SALVISAR | 503 286 | -11.8% | 1.3% | -0.2 | 191 430 973 | -0.1% | 1.1% | -0.2 | 3.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 860 | 7.9% | 14.1% | 1.1 | 15 022 475 | 12.0% | 10.2% | 1.1 | -0.5% |
| BRAINMAX | 1 410 | 40.9% | 100.0% | 0 | 5 650 664 | 51.3% | 100.0% | 0 | 40.9% |
| GOLDLINE PLUS | 14 385 | -0.1% | 45.3% | -1.2 | 44 213 790 | -1.0% | 37.0% | -1.6 | 2.6% |
| MIGRENIUM | 12 411 | 21.3% | 0.6% | 0.1 | 4 123 609 | 18.4% | 0.8% | 0.1 | -0.7% |
| MODELAX-N | 24 541 | 17.7% | 20.6% | 3 | 11 470 150 | 16.2% | 13.7% | 2 | 0.7% |
| REDUXIN CAPS | 10 427 | 4.7% | 32.8% | 0.7 | 52 733 780 | 5.0% | 44.2% | 0.8 | 2.6% |
| REDUXIN FORTE | 3 312 | 13.3% | 10.4% | 1 | 14 224 440 | 14.0% | 11.9% | 1.1 | 2.6% |
| SALVISAR | 8 285 | 6.9% | 1.2% | 0.1 | 3 574 930 | 3.1% | 1.1% | 0 | 0.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 33 561 | 12.5% | 13.2% | 1.4 | 64 687 077 | 4.5% | 9.7% | 0.5 | 0.2% |
| BRAINMAX | 5 212 | 11.0% | 100.0% | 0 | 19 612 893 | 12.5% | 100.0% | 0 | 11.2% |
| GOLDLINE PLUS | 68 010 | -10.6% | 46.4% | 0.7 | 212 403 736 | -10.0% | 38.3% | 0.8 | -12.0% |
| MIGRENIUM | 45 770 | -3.4% | 0.5% | -0.1 | 15 433 925 | -1.3% | 0.6% | -0.1 | 11.3% |
| MODELAX-N | 102 999 | -20.7% | 19.3% | -6.2 | 48 116 412 | -16.9% | 13.0% | -4 | 4.9% |
| REDUXIN CAPS | 48 170 | -9.4% | 32.8% | 1 | 247 736 086 | -11.8% | 44.6% | 0.1 | -12.0% |
| REDUXIN FORTE | 13 691 | -8.3% | 9.3% | 0.4 | 57 980 483 | -10.1% | 10.4% | 0.2 | -12.0% |
| SALVISAR | 34 936 | -11.1% | 1.1% | -0.2 | 15 667 203 | -7.6% | 1.1% | -0.1 | 2.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs